← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANDA REPOSITORY · Approved 2025-11-21

Drug application

FDA Application #

ANDA218080

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ANDA REPOSITORY

Manufacturer

Guardian Drug Company

First approval

2025-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown